Severe Persistent Eczema in a Recipient of the Gam-COVID-Vac vaccine

Ameri, Maryam and Abolmaali, Meysam and Jawad Alwedaie, Sayed Mohammed and Nabavi, Mohammad and Rahimian, Neda and Mahmoodi Hamidabad, Negin (2022) Severe Persistent Eczema in a Recipient of the Gam-COVID-Vac vaccine. European Journal of Case Reports in Internal Medicine, 9 (1). pp. 1-3. ISSN 2284-2594

3042-Article Text-26685-1-10-20220111.pdf - Published Version

Download (749kB) | Preview
Official URL:


Since the beginning of the COVID-19 pandemic, efforts have been made to design safe and effective vaccines against SARS-CoV-2.Numerous vaccines have been designed and tested in limited clinical trials in various countries. Among them, the Sputnik V vaccine has shown a relatively safe profile and, to our knowledge, has no associated major side effects. We describe the case of a 40-year-old female healthcare worker who developed severe persistent eczematous lesions on the second day after she received the first dose of the Sputnik vaccine. The eczematous lesions were refractory to an antihistamine and persisted at the 1 month follow-up. Severe persistent eczematous lesions should be viewed as a potential side effect of vaccination with the Sputnik V vaccine. Moreover, a severe allergic reaction to a COVID-2019 vaccine may indicate the vaccine is ineffective in the recipient.

Item Type: Article
Uncontrolled Keywords: COVID-19, Sputnik V, eczema
Subjects: 600 Tecnologia - Scienze applicate > 610 Medicina e salute (Classificare qui la tecnologia dei servizi medici)
Depositing User: Marina Spanti
Date Deposited: 15 Mar 2022 16:55
Last Modified: 15 Mar 2022 16:55

Actions (login required)

View Item View Item